Sotorasib tablets 120mg/tablet, 56 tablets/box

Medication Safety Tips

Use this product according to its instructions, medical advice, and your health needs. Shipping is arranged after payment once the order meets dispatch requirements.

Contraindications

Warnings and Precautions
• Hepatotoxicity: Hepatic function is monitored every 3 weeks for 3 months prior to treatment and then monthly as clinically indicated. Suspend, reduce the dose, or permanently discontinue LuciSot, depending on the severity.
• Interstitial lung disease (ILD)/pneumonia: Monitor for new or worsening lung symptoms. If ILD/pneumonia is suspected, immediately discontinue LuciSot; if no other potential cause of ILD/pneumonia is identified, permanently discontinue.

Medication risks

Adverse Reactions
The most common adverse reactions (≥ 20%) are diarrhea, musculoskeletal pain, nausea, fatigue, hepatotoxicity, and cough. The most common laboratory abnormalities (≥ 25%) are lymphopenia, hemoglobin decreased, aspartate aminotransferase increased, alanine aminotransferase increased, calcium decreased, alkaline phosphatase increased, urine protein increased, and sodium decreased.